Cargando…

Targeting growth hormone receptor in human melanoma cells attenuates tumor progression and epithelial mesenchymal transition via suppression of multiple oncogenic pathways

Recent reports have confirmed highest levels of growth hormone (GH) receptor (GHR) transcripts in melanoma, one of the most aggressive forms of human cancer. Yet the mechanism of GH action in melanoma remains mostly unknown. Here, using human malignant melanoma cells, we examined the effects of GH e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Basu, Reetobrata, Wu, Shiyong, Kopchick, John J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400608/ https://www.ncbi.nlm.nih.gov/pubmed/28223541 http://dx.doi.org/10.18632/oncotarget.15375

Ejemplares similares

THU549 Targeting The Growth Hormone Receptor Attenuates Tumor Exosome Mediated Propagation Of Chemoresistance In Melanoma
por: Kulkarni, Prateek, et al.
Publicado: (2023)

Effects of Growth Hormone in Human Melanoma Drug Resistance
por: Arora, Pranay, et al.
Publicado: (2021)

Growth Hormone Upregulates Mediators of Melanoma Drug Efflux and Epithelial-to-Mesenchymal Transition In Vitro and In Vivo
por: Qian, Yanrong, et al.
Publicado: (2020)

The effects of growth hormone on therapy resistance in cancer
por: Basu, Reetobrata, et al.
Publicado: (2019)

OR0304 Novel Dual Antagonists Of The Growth Hormone Receptor And The Prolactin Receptor
por: Basu, Reetobrata, et al.
Publicado: (2023)

A Novel Peptide Antagonist of the Human Growth Hormone Receptor
por: Basu, Reetobrata None, et al.
Publicado: (2021)

Effects of Growth Hormone on Pancreatic Cancer Derived Exosomes
por: Kulkarni, Prateek, et al.
Publicado: (2021)

SAT-LB053 Investigating the Effects of Growth Hormone on Tumor-derived Exosome Output and Content
por: Kulkarni, Prateek, et al.
Publicado: (2019)

OR05-04 Growth Hormone Receptor Antagonism Markedly Improves Therapeutic Response In Mouse Models Of Melanoma, Liver Cancer, Pancreatic Cancer And Cholangiocarcinoma
por: Basu, Reetobrata, et al.
Publicado: (2023)

THU545 Growth Hormone Receptor Antagonist As A Novel Combination Therapy Against Triple Negative Breast Cancer
por: Mora-Criollo, Patricia, et al.
Publicado: (2023)

Growth Hormone Receptor Inhibition Sensitizes Human Pancreatic Cancer to Chemotherapy Treatments
por: Basu, Reetobrata, et al.
Publicado: (2021)

SUN-336 Autocrine / Paracrine Growth Hormone (GH) Drives Multimodal Therapy Resistance in Growth Hormone Receptor (GHR)-expressing Human Cancers
por: Basu, Reetobrata, et al.
Publicado: (2019)

A novel peptide antagonist of the human growth hormone receptor
por: Basu, Reetobrata, et al.
Publicado: (2021)

SAT-181 Characterization of Adult Growth Hormone Receptor Gene-Disrupted Mice
por: Duran-Ortiz, Silvana, et al.
Publicado: (2019)

SAT-LB054 Growth Hormone Receptor (GHR) Antagonism Suppresses Hepatocellular Carcinoma Growth in a Syngeneic Mouse Model
por: Mathes, Samuel, et al.
Publicado: (2019)

Protein 4.1B Suppresses Tumor Metastasis by Regulating Epithelial-mesenchymal Transition Progression in Melanoma Cells
por: Wang, Chengbo, et al.
Publicado: (2019)

Crosstalk of Oncogenic Signaling Pathways during Epithelial–Mesenchymal Transition
por: Lindsey, Stephan, et al.
Publicado: (2014)

Reversing an Oncogenic Epithelial-to-Mesenchymal Transition Program in Breast Cancer Reveals Actionable Immune Suppressive Pathways
por: Williams, Michelle M., et al.
Publicado: (2021)

Structure and function of a dual antagonist of the human growth hormone and prolactin receptors with site-specific PEG conjugates
por: Basu, Reetobrata, et al.
Publicado: (2023)

Atezolizumab and Bevacizumab Attenuate Cisplatin Resistant Ovarian Cancer Cells Progression Synergistically via Suppressing Epithelial-Mesenchymal Transition
por: Zhang, Lei, et al.
Publicado: (2019)

Olive leaf extract inhibits metastatic melanoma spread through suppression of epithelial to mesenchymal transition
por: De Cicco, Paola, et al.
Publicado: (2022)

SELENBP1 inhibits progression of colorectal cancer by suppressing epithelial–mesenchymal transition
por: Zhang, Xiaotian, et al.
Publicado: (2022)

Ubiquitin ligase UBE3C promotes melanoma progression by increasing epithelial-mesenchymal transition in melanoma cells
por: Tang, Li, et al.
Publicado: (2016)

Epithelial-mesenchymal transition in glioblastoma progression
por: IWADATE, YASUO
Publicado: (2016)

The oncogenic E3 ligase TRIP12 suppresses epithelial–mesenchymal transition (EMT) and mesenchymal traits through ZEB1/2
por: Lee, Kwok Kin, et al.
Publicado: (2021)

Bergamottin Suppresses Metastasis of Lung Cancer Cells through Abrogation of Diverse Oncogenic Signaling Cascades and Epithelial-to-Mesenchymal Transition
por: Ko, Jeong-Hyeon, et al.
Publicado: (2018)

High growth hormone serum partially protects mice against Trypanosoma cruzi infection
por: Mora‐Criollo, Patricia, et al.
Publicado: (2023)

SCARA5 inhibits gastric cancer progression via epithelial-mesenchymal transition suppression
por: Zhang, Hangyu, et al.
Publicado: (2021)

Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression
por: Grant, Campbell M., et al.
Publicado: (2013)

Growth Hormone Upregulates Melanocyte-Inducing Transcription Factor Expression and Activity via JAK2-STAT5 and SRC Signaling in GH Receptor-Positive Human Melanoma
por: Basu, Reetobrata, et al.
Publicado: (2019)

Effects of Epithelial to Mesenchymal Transition on T Cell Targeting of Melanoma Cells
por: Woods, Katherine, et al.
Publicado: (2014)

A Histone Deacetylase Inhibitor Suppresses Epithelial-Mesenchymal Transition and Attenuates Chemoresistance in Biliary Tract Cancer
por: Sakamoto, Takuya, et al.
Publicado: (2016)

Growth Hormone Receptor Gene Disruption in Mature-Adult Mice Improves Glucose Metabolism and Lifespan in Females
por: Duran-Ortiz, Silvana, et al.
Publicado: (2021)

Gene co-expression and histone modification signatures are associated with melanoma progression, epithelial-to-mesenchymal transition, and metastasis
por: Azevedo, Hátylas, et al.
Publicado: (2020)

Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway
por: Zang, Ming-de, et al.
Publicado: (2017)

DAL-1 attenuates epithelial-to mesenchymal transition in lung cancer
por: Chen, Xianliang, et al.
Publicado: (2015)

Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition
por: Kyung, Sun Young, et al.
Publicado: (2018)

SAT-041 Bioinformatic Analysis of Human Cutaneous Melanomas Identifies Increased Mortality and Genetic Alterations in GH-responsive Tumors
por: Kruse, Colin P.S., et al.
Publicado: (2019)

RYBP Inhibits Progression and Metastasis of Lung Cancer by Suppressing EGFR Signaling and Epithelial-Mesenchymal Transition()()
por: Dinglin, Xiaoxiao, et al.
Publicado: (2017)

Oncogene FOXK1 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition
por: Wu, Yao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bdk0cchkalrdoft7umuuamj97r